Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"CAR-T"|"cell therapy" - Google News
Get the latest updates from "CAR-T"|"cell therapy" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 7 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's
FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy - statnews.com
8 months ago
FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy...
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's
Beth Israel doctors on high cancer remission rates that show the potential of CAR T cell therapy - The Business Journals
7 months ago
Beth Israel doctors on high cancer remission rates that show the potential...
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's
CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis - Science | AAAS
12 months ago
CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis...
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's
Early Data Show Deep MRD-Negative Responses, CAR T-Cell Persistence With KLN-1010 in R/R Myeloma - OncLive
10 months ago
Early Data Show Deep MRD-Negative Responses, CAR T-Cell Persistence With KLN-1010 in...
FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment - Memorial Sloan Kettering Cancer Center
10 months ago
FDA Approves Marginal Zone Lymphoma CAR T Cell Treatment Memorial Sloan Kettering...
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's
Early Data Show Promising Outcomes as CAR T-Cell Therapy Expands Beyond Academic Centers - The American Journal of Managed Care® (AJMC®)
8 months ago
Early Data Show Promising Outcomes as CAR T-Cell Therapy Expands Beyond Academic...
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion - Barron's
8 months ago
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion Barron's